- 10:42 PM Are stricter rules for MF advertisements on anvil?
- 10:31 PM NSE to launch new MF service system on Nov 30
- 10:16 PM India indispensable to America's future: Barack Ob...
- 10:00 PM Subir Gokarn’s agenda:Stimulus exit not to hit eco...
- 09:16 PM Worst over for India auto companies: Anand Mahindr...
- 08:52 PM Edelweiss, Tokio Marine ink insurance JV
- 08:42 PM Aviation biz to contribute 5% to rev in 3-5 years:...
- 08:24 PM Inflow of money will not help curb inflation: Bima...
- 07:17 PM MphasiS Q4 cons net profit up 33.9% at Rs 245 cr
- 06:59 PM Immediate supports for rupee at 46.20/46.10: Commt...
Ranbaxy Laboratories has announced its Q4CY06 results. The company posted net profit of Rs 185.9 crore in the fourth quarter versus Rs 68.6 crore in the corresponding quarter of the previous year, up by 170.99%.
Its revenues were up 21.5% at Rs 1707.7 crore from Rs 1405.5 crore, year-on-year. CNBC-TV18's research analyst Sunita Nagpal reviews the numbers.
|
Also Read
RSS feed for news |
For a complete review, watch video.
|
|
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
-
Most Read
-
Most Viewed
- 10 Companies that FIIs love
- 10 companies that MF managers love
- Mitesh Thacker's top 5 picks for trade today
- Ganeshaspeaks: Market prediction for Nov 24
- Will ITC dream run continue beyond FY10?
- Den Networks slips 22% after listing at Rs 195
- Trading in MF units to start in 15 days: SEBI
- Why LyondellBasell is a goldmine for RIL
- Experts see mkts at new highs, advise sectors
- Corrections in '10 to be more aggressive, violent: JPMorgan
- Mahindra may increase car prices due to rising input costs
Source: Business Line
- Renault to continue with M&M for Logan, says Ghosn
Source: Business Line
- Market volatility poses valuation problems: IRDA
Source: Business Line
- Punjab, Haryana buck all-India rice decline trend
Source: Business Line
